Ideation and Implementation of an Open Science Drug Discovery Business Model
M4K Pharma was incorporated to launch an open science drug discovery program that relies on regulatory exclusivity as its primary intellectual property and commercial asset, in lieu of patents. In many cases and in key markets, using regulatory exclusivity can provide equivalent commercial protection to patents, while also being compatible with open science. The model is proving attractive to government, foundation and individual funders, who collectively have different expectations for returns on investment compared with biotech, pharmaceutical companies, or venture capital investors.In the absence of these investor-driven requirements for returns, it should be possible to commercialize therapeutics at affordable prices. M4K is piloting this open science business model in a rare paediatric brain tumour, but there is no reason it should not be more widely applicable.
University of California Challenges Elsevier over Access to Scholarly Research
University of California System is playing hardball with Elsevier in negotiations that could transform the way it pays to read and publish research. But does the UC system have the clout to pull it off?
Springer Nature and Publons Enter Wide-ranging Partnership to Bring Greater Efficiency and Recognition to Peer Review
The burden on the peer review community is increasing as the volume of published research articles grows. Research output is rising exponentially and this is putting pressure on the system, with many academics inundated with requests to peer review. The recent Global State of Peer Review report highlights a growing “reviewer fatigue”.To help address this, Springer Nature and Publons, part of Clarivate Analytics, have announced a partnership to improve the peer review process and enable peer reviewers to receive recognition for their contribution.
An ERC Grant is the most prestigious award for excellent European research projects. A team with three researchers from the ETH Domain had also applied for such a grant. Today, Gabriel Aeppli from the Paul Scherrer Institute PSI, Henrik Rønnow from the Swiss Federal Institute of Technology Lausanne EPFL and Nicola Spaldin from ETH Zurich, together with their colleague Alexander Balatsky from Nordita, Stockholm University, received the contract signed by the EU confirming the extraordinary 14 million euro funding.
Peer review is lauded in principle as the guarantor of quality in academic publishing and grant distribution. But its practice is often loathed by those on the receiving end. Here, seven academics offer their tips on good refereeing, and reflect on how it may change in the years to come
Press release for launch of ORCID funders open letter. ORCID is pleased to announce the launch of an open letter in support of the use of ORCID identifiers (iDs) in the grant application and reporting process. Nine funding bodies around the world have signed the letter and invite others to join them.
The 14th Berlin Open Access Conference, hosted by the Max Planck Society and organized by the Max Planck Digital Library on behalf of the Open Access 2020 Initiative (oa2020.org), has just come to an end after two intense days with 170 participants from 37 countries around the world discussing where the research organizations and their library consortia stand in their negotiations with scholarly publishers in transitioning scholarly publishing to open access. The participants represented research performing and research funding organizations, libraries and government, associations of researchers and other umbrella organizations, many of them holding high-level positions at their organizations. In his welcoming address, Max Planck Society President Martin Stratmann captured the spirit of the meeting when he stated: "Open Access is the responsibility of all of us."
Sci-Hub "Pirate Bay of Science" Blocked in Russia Over Medical Studies
Many of Sci-Hub's domains have been blocked in Russia following a complaint from academic publisher Springer Nature that three studies covering heart and brain health were offered without obtaining an appropriate license.